T. Rowe Price Associates’s Arteris AIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5M Buy
443,481
+421,967
+1,961% +$13.5M ﹤0.01% 1129
2026
Q1
$354K Buy
21,514
+4,061
+23% +$64.4K ﹤0.01% 2604
2025
Q4
$271K Buy
17,453
+2,955
+20% +$42.8K ﹤0.01% 2692
2025
Q3
$147K Hold
14,498
– – ﹤0.01% 2856
2025
Q2
$139K Buy
14,498
+2,200
+18% +$16.2K ﹤0.01% 2822
2025
Q1
$85K Buy
12,298
+844
+7% +$8.07K ﹤0.01% 2860
2024
Q4
$117K Buy
+11,454
New +$94.6K ﹤0.01% 2806

Other funds holding AIP

T. Rowe Price Associates's AIP Position: Q2 2026 in Review

T. Rowe Price Associates increased its Arteris (AIP) stake by 1,961% in Q2 2026, buying an estimated $13.5M and bringing the position to 443,481 shares worth $21.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

T. Rowe Price Associates first reported a position in AIP in Q4 2024 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold AIP as of Q2 2026.

  • T. Rowe Price Associates held 443,481 shares of Arteris worth $21.5M as of Q2 2026.
  • T. Rowe Price Associates bought 421,967 Arteris shares in Q2 2026, an estimated $13.5M.
  • Arteris made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1129 holding.
  • T. Rowe Price Associates first reported a position in Arteris in Q4 2024 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Arteris as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.